Advertisement

Tumor Biology

, Volume 34, Issue 5, pp 3077–3082 | Cite as

The associations between the polymorphisms of the ER-α gene and the risk of uterine leiomyoma (ULM)

  • Yi Feng
  • Xiaojuan Lin
  • Shengtao Zhou
  • Ning Xu
  • Tao Yi
  • Xia Zhao
Research Article

Abstract

The ER-α gene polymorphisms have been reported to be associated with uterine leiomyoma (ULM) risk. The purpose of the present study was to perform a meta-analysis to explore the polymorphisms in the ER-α gene and the risk of ULM. A comprehensive search for relevant articles was conducted in MEDLINE (Ovid), PubMed, Embase, Springer, EBSCO, Web of Science, CNKI, Wanfang, Weipu, and Google Scholar. A total of nine articles were identified. Among the nine articles, 11 cohorts reported the PvuII polymorphism and six reported the XbaI polymorphism. The strength of the relationships between the polymorphisms in ER-α (PvuII and XbaI) and the risk of ULM was assessed by odds ratios (ORs). The studies provided overall OR estimates for PvuII and XbaI, leading to a pooled OR of 1.41 (PP+Pp vs. pp: OR = 1.41, 95 % confidence interval (95 %CI) = 1.02–1.96, P = 0.04), 1.13 (XX+Xx vs. xx: OR = 1.13, 95 %CI = 0.91–1.41, P = 0.25), respectively. The PvuII polymorphism in the ER-α gene may be a risk factor for ULM. Future studies are needed to validate our conclusions.

Keywords

Uterine leiomyoma ER-α gene Meta-analysis Polymorphism 

Notes

Acknowledgment

This research was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No.20120181120054).

Conflicts of interest

None

References

  1. 1.
    Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725–36.CrossRefPubMedGoogle Scholar
  2. 2.
    Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111(8):1037–54.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589–92.CrossRefPubMedGoogle Scholar
  4. 4.
    Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil. 2011;12(3):181–91.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Burns KA, Korach KS. Estrogen receptors and human disease: an update. Arch Toxicol. 2012;86(10):1491–504.CrossRefPubMedGoogle Scholar
  6. 6.
    Wang S, Zhu J, Zhang R, Wang S, Gu Z. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer. Tumour Biol. 2013;34(2):1045–52.CrossRefPubMedGoogle Scholar
  7. 7.
    Zhao ZQ, Guan QK, Yang FY, Zhao P, Zhou B, Chen ZJ. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk. Tumour Biol. 2012;33(2):523–35.CrossRefPubMedGoogle Scholar
  8. 8.
    Liu C, Yin Q, Hu J, Li L, Zhang Y, Wang Y. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility. Tumour Biol. 2013;34(2):1205–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhai XD, Ye Y, Yang Y, Wang Z, Mo YN. No association between estrogen receptor beta polymorphisms and uterine leiomyoma. DNA Cell Biol. 2009;28:633–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Fischer C, Juhasz-Boess I, Lattrich C, Ortmann O, Treeck O. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids. Gynecol Endocrinol. 2010;26(1):4–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Cha PC, Takahashi A, Hosono N, Low SK, Kamatani N, Kubo M, et al. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat Genet. 2011;43(5):447–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Wise LA, Ruiz-Narvaez EA, Palmer JR, Cozier YC, Tandon A, Patterson N, et al. African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol. 2012;176(12):1159–68.PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Hsieh YY, Chang CC, Tsai FJ, Tsai HD, Yeh LS, Lin CC, et al. Estrogen receptor thymine–adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril. 2003;79(1):96–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA, et al. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids. 2006;71(11–12):960–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Ye L, Feng LH, Liu YG, Shi JP, Jin H, Wang CH, et al. Analysis of association between estrogen receptor-alpha polymorphisms and uterine leiomyoma. J Jilin Univ Med Ed. 2009;35(1):96–9.Google Scholar
  16. 16.
    El-Shennawy GA, Elbialy AA, Isamil AE, El Behery MM. Is genetic polymorphism of ER-alpha, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma? Arch Gynecol Obstet. 2011;283(6):1313–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Shaik NA, Lone WG, Khan IA, Rao KP, Kodati VL, Hasan Q. Enhanced transcription of estrogen receptor alpha and mitochondrial cytochrome b genes in uterine leiomyomas. Gynecol Endocrinol. 2011;27(12):1094–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, et al. Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod. 2001;16(1):51–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Pakiz M, But I, Potocnik U. Are solitary and multiple uterine myomas two different diseases? Preliminary results of case control study. Gynecol Surg. 2009;6 Suppl 1:S179–80.Google Scholar
  20. 20.
    Chen FQ, Zhu XP, Qian XH, Yang YQ, Fan LA. The study on the relationship between polymorphism of estrogen receptor-alpha gene and leiomyomata. J Clin Obstet Gynecol. 2006;7(4):290–1.Google Scholar
  21. 21.
    Wang JY, Zhang HZ, Guan YQ, Zhou Q. Estrogen receptor α gene polymorphisms in women with leiomyoma. Beijing Med J. 2010;32(11):880–2.Google Scholar
  22. 22.
    Wang XL, Ceng J, Chen JH, Hu T, Xiong WC, Wang WM, et al. Association between estrogen receptor-alpha gene polymorphism and uterine leiomyomas. Sichuan Med J. 2010;31(12):1740–3.Google Scholar
  23. 23.
    Govindan S, Shaik NA, Vedicherla B, Kodati V, Rao KP, Hasan Q. Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers. 2009;26(4):149–54.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen receptor alpha-351 xbai*g and −397 pvuii*c-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod. 2007;13(2):117–22.CrossRefPubMedGoogle Scholar
  25. 25.
    Denschlag D, Bentz EK, Hefler L, Pietrowski D, Zeillinger R, Tempfer C, et al. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome p450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril. 2006;85(2):462–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril. 2006;86(3):686–93.CrossRefPubMedGoogle Scholar
  27. 27.
    Massart F, Becherini L, Marini F, Noci I, Piciocchi L, Del Monte F, et al. Analysis of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Med Sci Monit. 2003;9(1):BR25–30.PubMedGoogle Scholar
  28. 28.
    Massart F, Becherini L, Gennari L, Facchini V, Genazzani AR, Brandi ML. Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas. Fertil Steril. 2001;75(3):567–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Barbieri RL. Ambulatory management of uterine leiomyomata. Clin Obstet Gynecol. 1999;42(2):196–205.CrossRefPubMedGoogle Scholar
  30. 30.
    Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, Tang MS, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005;20(4):852–63.CrossRefPubMedGoogle Scholar
  31. 31.
    Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006;13(2):136–44.CrossRefPubMedGoogle Scholar
  32. 32.
    Pakiz M, Potocnik U, But I, Mujezinovic F. A CYP17A1 gene polymorphism in association with multiple uterine leimyomas; a meta-analysis. Cancer Biomark. 2010–2011;8(1):29–34.Google Scholar
  33. 33.
    Othman EE, Al-Hendy A. Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):589–601.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Yi Feng
    • 1
  • Xiaojuan Lin
    • 1
  • Shengtao Zhou
    • 1
  • Ning Xu
    • 1
  • Tao Yi
    • 1
  • Xia Zhao
    • 1
    • 2
  1. 1.Department of Gynecology and Obstetrics, Key Laboratory of Obstetrics and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second HospitalSichuan UniversityChengduPeople’s Republic of China
  2. 2.The State Key Laboratory of Biotherapy, West China HospitalSichuan UniversityChengduPeople’s Republic of China

Personalised recommendations